Device Brand Name Disclosure Would Be Required Under CMS Open Payments Proposals
This article was originally published in The Gray Sheet
Executive Summary
The agency says it wants to make some changes to the Open Payments (Sunshine Act) rules governing what device and drug firms disclose about physician and teaching hospital payments. Among the proposed changes: device firms would have to include brand names in disclosures to the public database.